Therefore, in the present study, we explore the biological significance of TIE-1 in the PI3K/Akt signaling pathway and demonstrate a novel molecular mechanism of action for TIE-1 in ovarian cancer, identifying TIE-1 as a target for the treatment of high-PI3K-expressing ovarian cancer. This evidence concerns the gene PIK3CA and ovarian cancer.